Jonathan Zalevsky - Chief R&D Officer at Nektar Therapeutics

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief R&D Officer
Stock Symbol
NKTR on Nasdaq
All Insider Reports
All Insider Reports

Jonathan Zalevsky - trading volume in the past year for Nektar Therapeutics

Holdings reported by Jonathan Zalevsky for Nektar Therapeutics

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 327K $307K $0.94 Dec 19, 2024 Direct
Stock Option 375K Dec 13, 2024 Direct Common Stock

Transactions reported by Jonathan Zalevsky for Nektar Therapeutics

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.